相关实验视频
Updated: Jun 21, 2025

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
萨库比特里尔-瓦尔萨坦对与衰老有关的心脏功能障碍的影响
Marialucia Telesca1, Antonella De Angelis1, Maria Donniacuo2
1Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Via Costantinopoli 16, 80138, Naples, Italy.
European journal of pharmacology
|July 5, 2024
概括
萨库比特里尔/瓦尔萨坦和瓦尔萨坦治疗减少了老年老鼠的心脏缩,但没有改善腹功能障碍或纤维化. 这两种药物都在老年心脏中部分恢复了心脏保护性氨酸- ангиотензин- алдостерон系统 (RAAS) 信号传递.
科学领域:
- 心脏病学 心脏病学
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 衰老是心力衰竭 (HF) 的一个主要危险因素,特别是心力衰竭与保留射出分数 (HFpEF) 的心力衰竭.
- 目前与衰老相关的HFpEF治疗方法有限.
研究的目的:
- 调查萨库比特里尔/瓦尔萨坦和瓦尔萨坦对与衰老相关的HFpEF的实验模型的影响.
- 评估这些药物对心脏缩,纤维化,透缩功能障碍和氨酸-血管氨酸-氨酸系统 (RAAS) 信号传导的影响.
主要方法:
- 18个月大的雌性Fisher 344只老化相关HFpEF的老鼠被用sacubitril/valsartan或 valsartan治疗了12周.
- 三个月大的老鼠作为对照.
- 评估心脏结构,功能和RAAS信号使用心声回声,导管和分子分析.
主要成果:
- 萨库比特里尔/瓦尔萨坦和瓦尔萨坦都显著降低了心脏缩,通过减少肌细胞壁厚度和肌细胞横截面积来证明这一点.
- 两种治疗都没有减少心肌纤维化或改善衰老老鼠的腹功能障碍.
- 与未经治疗的老老鼠相比,这两种药物都部分恢复了心脏保护性非经典RAAS信号传递.
- 在接受治疗的老老鼠中,心肌炎症,内皮激活和氧化应激持续存在.
结论:
- 萨库比特里尔/瓦尔萨坦和瓦尔萨坦通过减弱心肌细胞大小,对与年龄相关的心脏缩产生有利影响.
- 观察到的好处可能包括向心脏保护性RAAS信号转移.
- 透支功能障碍和心脏纤维化仍然是老年心脏的重大挑战,尽管这些治疗方法仍然存在.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
Antihypertensive Drugs: Angiotensin II Receptor Blockers
695
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
695
Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Aging
41
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
41

